BioCentury
ARTICLE | Company News

Novartis, Mereo BioPharma deal

August 3, 2015 7:00 AM UTC

Start-up Mereo acquired three Phase II compounds from Novartis in exchange for an undisclosed equity stake. Novartis is eligible for milestone payments and royalties. BPS-804 is a human mAb for the O...